Northwire Canada EditionTuesday, July 21, 2026
Sign inSubscribe
Northwire
⌕
LOD 0.280 −5.1% FVL 0.960 +5.5% BAG 0.210 +23.5% FMN 0.240 +0.0% OMM 0.050 +0.0% VUL 0.405 +0.0% PNTR 0.320 +8.5% SWA 0.035 +0.0% GEN 0.065 +0.0% PAT 0.355 +0.0% TOM 0.115 +9.5% ALS 57.05 +0.2% LIO 0.130 −7.1% GEMC 0.020 +0.0% CBA 0.070 +7.7% PUMA 0.110 +0.0% LOD 0.280 −5.1% FVL 0.960 +5.5% BAG 0.210 +23.5% FMN 0.240 +0.0% OMM 0.050 +0.0% VUL 0.405 +0.0% PNTR 0.320 +8.5% SWA 0.035 +0.0% GEN 0.065 +0.0% PAT 0.355 +0.0% TOM 0.115 +9.5% ALS 57.05 +0.2% LIO 0.130 −7.1% GEMC 0.020 +0.0% CBA 0.070 +7.7% PUMA 0.110 +0.0%

Healthcare

Page 128
  1. Sep 16, 2025 · 14:52 · HEM

    Hemostemix to Present Its Clinical Data of the Treatment of Severe Angina

    Hemostemix to Present Its Clinical Data of the Treatment of Severe Angina

    01
  2. Sep 15, 2025 · 23:29 · DTC

    Defence Therapeutics closes debenture unit financing

    Defence Therapeutics closes debenture unit financing

    02
  3. Sep 15, 2025 · 19:16 · AIDR

    Rocket Doctor, Town of Bruderheim enter partnership

    Rocket Doctor, Town of Bruderheim enter partnership

    03
  4. Sep 15, 2025 · 12:40 · BNXT

    Bionxt finishes semaglutide ODF proof-of-concept trials

    Bionxt finishes semaglutide ODF proof-of-concept trials

    04
  5. Sep 12, 2025 · 20:56 · BNXT

    Bionxt to settle $225,010 of debt with shares, cash

    Bionxt to settle $225,010 of debt with shares, cash

    05
  6. Sep 12, 2025 · 16:32 · QNTM

    Quantum Biopharma licensee to hold webinar Sept. 16

    Quantum Biopharma licensee to hold webinar Sept. 16

    06
  7. Sep 12, 2025 · 01:22 · NRX

    Nurexone Biologic receives patent in Israel

    Nurexone Biologic receives patent in Israel

    07
  8. Sep 11, 2025 · 19:55 · BHC

    Bausch Health completes tender offer to acquire Durect

    Bausch Health completes tender offer to acquire Durect

    08
  9. Sep 11, 2025 · 16:46 · BLCO

    Bausch + Lomb says enVista Envy study meets end points

    Bausch + Lomb says enVista Envy study meets end points

    09
  10. Sep 11, 2025 · 04:04 · KNE

    Kane Biotech enrolls 28 participants for revyve studies

    Kane Biotech enrolls 28 participants for revyve studies

    10
  11. Sep 10, 2025 · 18:57 · QIPT

    Quipt holder/suitor Forager highlights premium in offer

    Quipt holder/suitor Forager highlights premium in offer

    11
  12. Sep 09, 2025 · 23:50 · LOBE

    Lobe Sciences Ltd. and Cynaptec Pharmaceuticals, Inc. to Present a New Therapeutic Approach for the Treatment of Chronic Cluster Headaches at Clusterbusters 2025

    Lobe Sciences Ltd. and Cynaptec Pharmaceuticals, Inc. to Present a New Therapeutic Approach for the Treatment of Chronic Cluster Headaches at Clusterbusters 2025

    12
  13. Sep 09, 2025 · 18:41 · AIDR

    Rocket Doctor hits 50-pharmacy milestone in Canada

    Rocket Doctor hits 50-pharmacy milestone in Canada

    13
  14. Sep 09, 2025 · 16:52 · BLCO

    Bausch notes Xiidra study shows eased lens discomfort

    Bausch notes Xiidra study shows eased lens discomfort

    14
← Newer Older →